IRON catalysts
Catalysts and events linked to IRON, newest first.
IRON stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Disc Medicine to Present Phase 2 Hematology Data at SOHO 2026 2026-09-01 · Up | clinical pipeline trial efficacy readout derisking | Disc Medicine presenting Phase 2 data for DISC-3405 and DISC-0974 at SOHO 2026 | Not recorded |
| Disc Medicine to Present Phase 2 RESTORE-PV and RALLY-MF Trial Data at SOHO 2026-09-01 · Up | clinical pipeline milestone readout | Disc Medicine presents RESTORE-PV and RALLY-MF Phase 2 trial results at SOHO 2026. | Not recorded |
Do these developments change your position?
Review IRON alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.